Search
for
Sort by
Research 361–390 of 535
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- New and Emerging Therapies for Alopecia Areata
- A Case of Topical Ruxolitinib Treatment Failure in Alopecia Areata
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- Comparative efficacy of oral Janus kinase inhibitors and biologics in adult alopecia areata: A systematic review and Bayesian network meta‐analysis
- Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors
- Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib
- Interleukin-15 is a hair follicle immune privilege guardian
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Use of Jak Inhibitors in the Treatment of Alopecia Areata
- Pharmacological activities of Abrus precatorius Linn.: A comprehensive review of its ethnomedicinal uses and phytochemical profile.
- Pharmacological activities of Abrus precatorius Linn.: A comprehensive review of its ethnomedicinal uses and phytochemical profile.
- Network pharmacology, molecular docking, and dynamics reveal the mechanisms of Hejie Shengfa Decoction against alopecia areata
- Approach to Managing Recalcitrant Alopecia Areata with Combination Therapy: A Series of Five Cases in Black Pediatric Patients
- 054 Deep Analysis of CD4+ Trm Cells in Normal and Atopic Dermatitis Human Skin
- <i>IKZF1</i> and Ikaros Overexpression Results in Alopecia Areata‐Like Phenotype in Mice
- Hair follicle targeting via gelatin coated transferosomes loaded with tofacitinib citrate for enhanced treatment of alopecia areata: Clinical evaluation of alopecia areata patients
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- 290 Brepocitinib improves cicatricial alopecia and downregulates key T-helper biomarkers
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- 056 IKZF1 and IKAROS overexpression contributes to the pathogenesis of alopecia areata
- 1432 IL-9/IL-9R signaling as a novel regulator of human hair follicle growth and immune privilege
- A perspective on predictive markers of alopecia
- 865 Frontal fibrosing alopecia is associated with dysregulation of cholesterol biosynthesis pathways, fibrosis and mast cells
- Are Janus kinase (JAK) inhibitors beneficial in the treatment of androgenic alopecia?